4 days ago
ERA 2025
Semaglutide Significantly Improves Chronic Kidney Disease The landmark FLOW study shows the benefits extend to kidney, cardiovascular, and mortality outcomes in high-risk patients with type 2 diabetes and CKD. Medscape Medical News , May 24, 2024
Semaglutide Significantly Improves Chronic Kidney Disease Antinephrin Autoantibodies: Biomarker for Kidney Disease? Using an innovative analysis technique, researchers identified antinephrin autoantibodies as markers of difficult to diagnose kidney diseases. Medscape Medical News , May 26, 2024
Antinephrin Autoantibodies: Biomarker for Kidney Disease? SGLT2 Inhibitors Add to GLP-1s' Cardio, Kidney Benefits The largest analysis to date details added effects of SGLT2 inhibitors among those with type 2 diabetes when combined with GLP-1 receptor agonists.
Medscape Medical News, Jun 03, 2024
